Ameritas Investment Partners’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Ameritas Investment Partners’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,554	Closed	-$11K	–	3312
2022 Q1	$11K	Hold	3,554	–	–	﹤0.01%	2782
2021 Q4	$16K	Hold	3,554	–	–	﹤0.01%	2749
2021 Q3	$17K	Hold	3,554	–	–	﹤0.01%	2790
2021 Q2	$24K	Hold	3,554	–	–	﹤0.01%	2660
2021 Q1	$25K	Hold	3,554	–	–	﹤0.01%	2478
2020 Q4	$22K	Hold	3,554	–	–	﹤0.01%	2432
2020 Q3	$19K	Buy	3,554 +1,485	+72%	+$7.35K	﹤0.01%	2415
2020 Q2	$11K	Hold	2,069	–	–	﹤0.01%	2691
2020 Q1	$7K	Hold	2,069	–	–	﹤0.01%	2717
2019 Q4	$8K	Hold	2,069	–	–	﹤0.01%	2819
2019 Q3	$9K	Hold	2,069	–	–	﹤0.01%	2795
2019 Q2	$8K	Hold	2,069	–	–	﹤0.01%	2872
2019 Q1	$11K	Hold	2,069	–	–	﹤0.01%	2674
2018 Q4	$11K	Hold	2,069	–	–	﹤0.01%	2641
2018 Q3	$20K	Hold	2,069	–	–	﹤0.01%	2520
2018 Q2	$21K	Hold	2,069	–	–	﹤0.01%	2496
2018 Q1	$27K	Hold	2,069	–	–	﹤0.01%	2271
2017 Q4	$37K	Hold	2,069	–	–	﹤0.01%	2099
2017 Q3	$58K	Hold	2,069	–	–	﹤0.01%	1799
2017 Q2	$50K	Buy	2,069 +487	+31%	+$10.8K	﹤0.01%	1907
2017 Q1	$30K	Buy	+1,582	New	+$24.9K	﹤0.01%	2170

Other funds holding PRTK

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Ameritas Investment Partners's PRTK Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2022, closing a stake of 3,554 shares — an estimated $11K sold.

Ameritas Investment Partners first reported a position in PRTK in Q1 2017 and held it in 21 quarters. The position peaked at $58K in Q3 2017. 84 funds tracked by Wall St. Rank hold PRTK as of Q2 2022.

Ameritas Investment Partners reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 3,554 Paratek Pharmaceuticals, Inc. shares in Q2 2022, an estimated $11K.
Ameritas Investment Partners first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2017 and held it in 21 quarters.
Ameritas Investment Partners's Paratek Pharmaceuticals, Inc. position peaked at $58K in Q3 2017.
84 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.